In a large Chinese cohort of ovarian cancer patients, RAD51D GPVs were detected in 1.7% (13/781), and this variant was found in seven patients and accounted for 53.8% of all RAD51D pathogenic variants [49]. The gene discussed is RAD51D; the disease is ovarian carcinoma.